ENTEST BIOMEDICAL, INC. (ENTB) SEC Filing 10-Q Quarterly report for the period ending Wednesday, November 30, 2016

Subscribe PDF Word MS-Excel Facebook Twitter Google+ Evernote Reddit E-mail Ask 9W Smartphone and Tablet last10k.com/sec-filings/entb/0001607062-17-000009.htm
Document and Entity Information
3 Months Ended
Nov. 30, 2016
shares
Document And Entity Information 
Entity Registrant NameENTEST BIOMEDICAL, INC.
Entity Central Index Key0001449447
Document Type10-Q
Document Period End DateNov. 30, 2016
Amendment Flagfalse
Current Fiscal Year End Date--08-31
Is Entity a Well-known Seasoned Issuer?No
Is Entity a Voluntary Filer?No
Is Entity's Reporting Status Current?Yes
Entity Filer CategorySmaller Reporting Company
Entity Common Stock, Shares Outstanding40,170,472
Document Fiscal Period FocusQ1
Document Fiscal Year Focus2016

Please wait while we load the requested 10-Q report. If it does not load, please click the link below:

https://www.last10k.com/sec-filings/entb/0001607062-17-000009.htm
  • Form Type: Quarterly
  • Number of times amended: 0
  • Accession Number: 0001607062-17-000009
  • Submitted to the SEC: Wednesday, January 11, 2017
  • Accepted by the SEC: Wednesday, January 11, 2017
  • Period Ending: November 2016
Companies
 

ENTB Morningstar

ENTEST BIOMEDICAL, INC.

$0.04 +0 (+0%)

Stock Exchange:
Over-the-Counter (OTC)

Day's Range:
N/A

52-Week Range:
$0.00 to $0.09

Volume:
N/A

Volume (Avg):
12,313,500

Earnings per Share:
$-0.01

PEG / Short / PE Ratios:
0.00 / 0.00 / N/A

Market Cap:
$1.61M

Book Value:
-0.03

EBITDA:
$0.00